Role of magnesium supplementation in the treatment of depression: A randomized clinical trial
Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C
PloS one · 80 citations
How it was studied
- Design
- Randomized controlled trial (indexed by PubMed)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Independent funding
- University or hospital
- University of Vermont
- University or hospital
- This work was supported by the Henry and Carleen Tufo fund of the University of Vermont.
Based on 2 listed funder(s) and full-text disclosure statement.
Publication
- Published
- 2017-06-27 · PLoS One · vol. 12 · issue 6 · p. e0180067
- Publisher
- Public Library of Science
- Cited
- 154 citations · more than 99% of similar papers · 7.7× the field average
- Impact
- Top 10% most cited in its field
- References
- 37 works
- Access
- Open access (journal) · CC-BY
- Research areas
- Magnesium in Health and Disease · Bipolar Disorder and Treatment · Aluminum toxicity and tolerance in plants and animals
- Keywords
- Medicine, Randomized controlled trial, Anxiety, Depression (economics), Regimen, Internal medicine, Patient Health Questionnaire, Pill, Adverse effect, Clinical trial, Physical therapy, Depressive symptoms, Psychiatry
- MeSH
- humans, magnesium chloride, antidepressive agents, treatment outcome, cross-over studies, depressive disorder, adult, aged, middle aged, female, male
5 authors
From US
- Emily K. Tarleton · correspondingUniversity of Vermont
- Benjamin LittenbergUniversity of Vermont
- Charles D. MacLeanUniversity of Vermont
- Amanda G. KennedyUniversity of Vermont
- Christopher DaleyUniversity of Vermont
Abstract
Current treatment options for depression are limited by efficacy, cost, availability, side effects, and acceptability to patients. Several studies have looked at the association between magnesium and depression, yet its role in symptom management is unclear. The objective of this trial was to test whether supplementation with over-the-counter magnesium chloride improves symptoms of depression. An open-label, blocked, randomized, cross-over trial was carried out in outpatient primary care clinics on 126 adults (mean age 52; 38% male) diagnosed with and currently experiencing mild-to-moderate symptoms with Patient Health Questionnaire-9 (PHQ-9) scores of 5-19. The intervention was 6 weeks of active treatment (248 mg of elemental magnesium per day) compared to 6 weeks of control (no treatment). Assessments of depression symptoms were completed at bi-weekly phone calls. The primary outcome was the net difference in the change in depression symptoms from baseline to the end of each treatment period. Secondary outcomes included changes in anxiety symptoms as well as adherence to the supplement regimen, appearance of adverse effects, and intention to use magnesium supplements in the future. Between June 2015 and May 2016, 112 participants provided analyzable data. Consumption of magnesium chloride for 6 weeks resulted in a clinically significant net improvement in PHQ-9 scores of -6.0 points (CI -7.9, -4.2; P<0.001) and net improvement in Generalized Anxiety Disorders-7 scores of -4.5 points (CI -6.6, -2.4; P<0.001). Average adherence was 83% by pill count. The supplements were well tolerated and 61% of participants reported they would use magnesium in the future. Similar effects were observed regardless of age, gender, baseline severity of depression, baseline magnesium level, or use of antidepressant treatments. Effects were observed within two weeks. Magnesium is effective for mild-to-moderate depression in adults. It works quickly and is well tolerated without the need for close monitoring for toxicity.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.